Histogen Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/485fab50-1a98-4474-8770-2174bd754732/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $3.8M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-007056 |
| FY 2021 | $1.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009664 |
| FY 2020 | $2.1M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012536 |
| FY 2019 | $11.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-012536 |
| FY 2018 | $33.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007030 |
| FY 2017 | $35.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007030 |
| FY 2016 | $799.0k | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-007030 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001564590-18-004914 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).